Mechanisms of action of antiseizure drugs

Roger J. Porter, Ashish Dhir, Robert L. Macdonald, Michael A Rogawski

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

This chapter reviews the current understanding of how each of the marketed antiseizure drugs acts on brain mechanisms to protect against seizures. Although the actions of each antiseizure drug have unique characteristics and some drugs may act by multiple mechanisms, the anticonvulsant actions of these drugs can be grouped into four broad categories. These are: (1) modulation of voltage-dependent sodium, calcium or potassium channels; (2) alterations in GABAergic inhibition via actions on GABA A receptors or on GABA synthesis, reuptake, or degradation; (3) decreased synaptic excitation via actions on ionotropic glutamate receptors; and (4) modulation of neurotransmitter release via presynaptic mechanisms. For some antiseizure drugs, the mechanism remains at least partially unknown. An understanding of mechanism may serve as a guide to clinicians as to the seizure types and syndromes that a particular drug may or may not be useful to treat. However, empirical clinical validation is required as the mechanism is not a foolproof predictor of clinical utility. Another use of mechanistic knowledge is to determine rational combinations of drugs for polytherapy. Finally, an understanding of the mechanism may allow the identification of new molecules that act in a mechanistically similar fashion but have improved properties.

Original languageEnglish (US)
Pages (from-to)664-681
Number of pages18
JournalHandbook of Clinical Neurology
Volume108
DOIs
StatePublished - 2012

Fingerprint

Pharmaceutical Preparations
Seizures
Ionotropic Glutamate Receptors
Sodium Channels
Potassium Channels
GABA-A Receptors
Calcium Channels
Combination Drug Therapy
Anticonvulsants
gamma-Aminobutyric Acid
Neurotransmitter Agents
Brain

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Mechanisms of action of antiseizure drugs. / Porter, Roger J.; Dhir, Ashish; Macdonald, Robert L.; Rogawski, Michael A.

In: Handbook of Clinical Neurology, Vol. 108, 2012, p. 664-681.

Research output: Contribution to journalArticle

Porter, Roger J. ; Dhir, Ashish ; Macdonald, Robert L. ; Rogawski, Michael A. / Mechanisms of action of antiseizure drugs. In: Handbook of Clinical Neurology. 2012 ; Vol. 108. pp. 664-681.
@article{9ed8a00f6b084f8cafb2c8ff4767ce55,
title = "Mechanisms of action of antiseizure drugs",
abstract = "This chapter reviews the current understanding of how each of the marketed antiseizure drugs acts on brain mechanisms to protect against seizures. Although the actions of each antiseizure drug have unique characteristics and some drugs may act by multiple mechanisms, the anticonvulsant actions of these drugs can be grouped into four broad categories. These are: (1) modulation of voltage-dependent sodium, calcium or potassium channels; (2) alterations in GABAergic inhibition via actions on GABA A receptors or on GABA synthesis, reuptake, or degradation; (3) decreased synaptic excitation via actions on ionotropic glutamate receptors; and (4) modulation of neurotransmitter release via presynaptic mechanisms. For some antiseizure drugs, the mechanism remains at least partially unknown. An understanding of mechanism may serve as a guide to clinicians as to the seizure types and syndromes that a particular drug may or may not be useful to treat. However, empirical clinical validation is required as the mechanism is not a foolproof predictor of clinical utility. Another use of mechanistic knowledge is to determine rational combinations of drugs for polytherapy. Finally, an understanding of the mechanism may allow the identification of new molecules that act in a mechanistically similar fashion but have improved properties.",
author = "Porter, {Roger J.} and Ashish Dhir and Macdonald, {Robert L.} and Rogawski, {Michael A}",
year = "2012",
doi = "10.1016/B978-0-444-52899-5.00021-6",
language = "English (US)",
volume = "108",
pages = "664--681",
journal = "Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn",
issn = "0072-9752",
publisher = "Elsevier",

}

TY - JOUR

T1 - Mechanisms of action of antiseizure drugs

AU - Porter, Roger J.

AU - Dhir, Ashish

AU - Macdonald, Robert L.

AU - Rogawski, Michael A

PY - 2012

Y1 - 2012

N2 - This chapter reviews the current understanding of how each of the marketed antiseizure drugs acts on brain mechanisms to protect against seizures. Although the actions of each antiseizure drug have unique characteristics and some drugs may act by multiple mechanisms, the anticonvulsant actions of these drugs can be grouped into four broad categories. These are: (1) modulation of voltage-dependent sodium, calcium or potassium channels; (2) alterations in GABAergic inhibition via actions on GABA A receptors or on GABA synthesis, reuptake, or degradation; (3) decreased synaptic excitation via actions on ionotropic glutamate receptors; and (4) modulation of neurotransmitter release via presynaptic mechanisms. For some antiseizure drugs, the mechanism remains at least partially unknown. An understanding of mechanism may serve as a guide to clinicians as to the seizure types and syndromes that a particular drug may or may not be useful to treat. However, empirical clinical validation is required as the mechanism is not a foolproof predictor of clinical utility. Another use of mechanistic knowledge is to determine rational combinations of drugs for polytherapy. Finally, an understanding of the mechanism may allow the identification of new molecules that act in a mechanistically similar fashion but have improved properties.

AB - This chapter reviews the current understanding of how each of the marketed antiseizure drugs acts on brain mechanisms to protect against seizures. Although the actions of each antiseizure drug have unique characteristics and some drugs may act by multiple mechanisms, the anticonvulsant actions of these drugs can be grouped into four broad categories. These are: (1) modulation of voltage-dependent sodium, calcium or potassium channels; (2) alterations in GABAergic inhibition via actions on GABA A receptors or on GABA synthesis, reuptake, or degradation; (3) decreased synaptic excitation via actions on ionotropic glutamate receptors; and (4) modulation of neurotransmitter release via presynaptic mechanisms. For some antiseizure drugs, the mechanism remains at least partially unknown. An understanding of mechanism may serve as a guide to clinicians as to the seizure types and syndromes that a particular drug may or may not be useful to treat. However, empirical clinical validation is required as the mechanism is not a foolproof predictor of clinical utility. Another use of mechanistic knowledge is to determine rational combinations of drugs for polytherapy. Finally, an understanding of the mechanism may allow the identification of new molecules that act in a mechanistically similar fashion but have improved properties.

UR - http://www.scopus.com/inward/record.url?scp=84865579645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865579645&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-52899-5.00021-6

DO - 10.1016/B978-0-444-52899-5.00021-6

M3 - Article

C2 - 22939059

AN - SCOPUS:84865579645

VL - 108

SP - 664

EP - 681

JO - Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn

JF - Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn

SN - 0072-9752

ER -